Paxman publ : publishes the company’s annual report for 2019

Today, PAXMAN publishes the company’s annual report for 2019.

The annual report in Swedish and a condensed English version is available on PAXMAN’s website. The Swedish version of the annual report is also available in print and can be ordered by emailing the company’s CFO Emelie Gustafsson, [e-mail].

Use the links below for quick access to the digital versions of the annual report.

Swedish version: https://bit.ly/paxar19se
Condensed English version: https://bit.ly/paxar19en

The annual report was created in collaboration with PAXMAN’s IR communication partner Honeybadger, https://www.honeybadger.se

For more information, please contact:

Richard Paxman, CEO
Tel: [phone]
Email: [e-mail]
www.paxman.se

About PAXMAN
The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With close to 3,000 systems delivered to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology. PAXMAN’s scalp-cooling cap is made from lightweight, biocompatible silicone that is soft and flexible, providing a snug yet comfortable fit during treatment. PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK) and Houston, Texas (US).

The PAXMAN share is listed on Nasdaq First North. FNCA Sweden AB is the company’s Certified Adviser and can be contacted via [e-mail] and [phone].

Contacts

---

Richard Paxman, CEO
Tel: [phone]
Email: [e-mail]
www.paxman.se

About Us

---

The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With close to 3,500 systems delivered in to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology. PAXMAN’s scalp-cooling cap is made from lightweight, biocompatible silicone that is soft and flexible, providing a snug yet comfortable fit during treatment. PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK) and Houston, Texas (US).

The PAXMAN share is listed on Nasdaq First North Growth Market. FNCA Sweden AB is the company’s Certified Adviser and can be contacted via [e-mail] and [phone].

Attachments

---

PAXMAN ÅR ENG

© Modular Finance, source Nordic Press Releases